Leadership, Planning and Evaluation

项目摘要-领导、规划和评价 Raphael Pollock，MD，PhD担任俄亥俄州州立大学综合癌症中心主任 （OSUCCC）。波洛克博士由一个由全国公认的癌症领导人组成的高级领导团队协助 研究，临床护理，预防和教育包括彼得希尔兹，医学博士（副主任）;威廉 卡森，医学博士（临床研究副主任）; Electra Paskett，博士（人口副主任 科学和社区外展）;帕特里克绿色，博士（基础科学副主任）;克莱尔 Verschraegen，MD（转化科学副总监）;石楠Hampel，MS，LGC（副总监 生物标本研究）; Sharyn Baker，PharmD，PhD（共享资源副总监）; Lawrence Kirschner，MD，PhD（教育和培训副总监）; John Byrd，MD（高级顾问）和大卫 Gosky，MA，MBA（行政执行董事）。这个经验丰富的高级领导团队 共同努力：确保OSUCCC的共同愿景和目标的一致性;促进协同和高度合作， 基础、人口、转化和临床研究组成部分之间的协作互动 OSUCCC;有效地利用OSU、州和国家各级的所有可用资源;从事临床试验， 社区外展、教育和指导;并监督OSUCCC的所有活动。持续规划 和评估是OSUCCC发展和持续卓越的关键，并有助于确保其 强大的科学轨迹。OSUCCC外部科学和内部咨询的规划和评估 理事会（分别为ESAB和IAB）、协理主任委员会（ADC）和其他理事会提供 董事和高级领导持续的指导和支持。西非经共体是主要的外部机制， 客观审查和监督OSUCCC，包括其在基础，翻译，人口和 社区研究及其领导力和战略方向。ADC，计划领导人委员会，共享 资源团队领导委员会和IAB（由OSU院长和研究副院长组成） 促进内部规划和评价。执行理事会负责癌症的统一愿景 OSUCCC-James的研究和临床项目，并为以下方面提供了另一个重要的内部机制： 规划和评价。波洛克博士和高级领导最近创建了OSUCCC-James战略 在现有的坚实基础上，制定今后五年的计划。新计划的首要目标是， 名为“攀登新高峰”的项目，旨在推动新的发现，在整个连续体中改变癌症护理 预防，治疗和生存，以改善OSUCCC集水区社区的健康。 支持整个生命周期研究的目标是由集水区癌症负担的数据提供信息的 地区并通过与社区咨询委员会的双向沟通。四大研究举措 （免疫肿瘤学，癌症工程，翻译基因组学，癌症预防和生存） 该计划将加速我们创造一个无癌症世界的愿景，一个人，一次一个发现。

PROJECT SUMMARY – LEADERSHIP, PLANNING AND EVALUATION Raphael Pollock, MD, PhD serves as Director for The Ohio State University Comprehensive Cancer Center (OSUCCC). Dr. Pollock is assisted by a Senior Leadership team of nationally recognized leaders in cancer research, clinical care, and prevention and education includes Peter Shields, MD (Deputy Director); William Carson, MD (Associate Director for Clinical Research); Electra Paskett, PhD (Associate Director for Population Sciences and Community Outreach); Patrick Green, PhD (Associate Director for Basic Science); Claire Verschraegen, MD (Associate Director for Translational Science); Heather Hampel, MS, LGC (Associate Director for Biospecimen Research); Sharyn Baker, PharmD, PhD (Associate Director for Shared Resources); Lawrence Kirschner, MD, PhD (Associate Director for Education and Training); John Byrd, MD (Senior Advisor) and David Gosky, MA, MBA (Executive Director for Administration). This highly experienced Senior Leadership team works together to: ensure consistency in the shared vision and goals of the OSUCCC; foster synergistic and highly collaborative interactions among the basic, population, translational and clinical research components of the OSUCCC; effectively leverage all available resources at OSU, state and national levels; engage in clinical trials, community outreach, education and mentoring; and oversee all activities of the OSUCCC. Continuous planning and evaluation are key to the development and sustained excellence of the OSUCCC, and helps ensure its strong scientific trajectory. Planning and evaluation by the OSUCCC External Scientific and Internal Advisory Boards (ESAB and IAB, respectively), the Associate Directors Committee (ADC), and other councils provide the Director and Senior Leadership ongoing guidance and support. The ESAB is the primary external mechanism for objective review and oversight of the OSUCCC, including its progress in basic, translational, population and community research, and its leadership and strategic direction. The ADC, Program Leaders Committee, Shared Resource Team Leaders Committee, and IAB (composed of OSU deans and associate deans of research) facilitate internal planning and evaluation. The Executive Council is responsible for the cohesive vision of cancer research and clinical programs of the OSUCCC-James and provides another important internal mechanism for planning and evaluation. Dr. Pollock and the Senior Leadership recently created the OSUCCC-James strategic plan for the next five years, building upon existing strong foundations. The overarching goal of the new plan, entitled Ascending to New Heights, is to drive new discoveries that transform cancer care across the continuum of prevention, treatment and survivorship to improve the health of the OSUCCC catchment area communities. Goals supporting research across the lifespan are informed by data about the cancer burden in the catchment area and through bidirectional communication with community advisory boards. Four major research initiatives (immuno-oncology, cancer engineering, translational genomics, and cancer prevention and survivorship) in the plan will accelerate our vision of creating a cancer-free world, one person, one discovery at a time.